Welcome to GSTS Pathology
GSTS Pathology LLP - the UK's leading independent provider of Pathology Services - is a unique and innovative joint venture between Guy's and St Thomas' and King's College Hospital NHS Foundation Trusts and Serco plc.
GSTS is an exemplar of public private partnership in the health sector. The vision is to combine the established clinical and scientific excellence of Guy’s and St Thomas’ and King's College Hospitals, with the proven transformation and innovation skills of Serco.
Latest News
GSTS-KingsPath will have a stand at BioMedica 2012 at Dublin's...
GSTS/KingsPath recently exhibited at the bi-annual IBMS Congress at the International...
GSTS-KingsPath will have a stand at the Biomedical Science Congress...
GSTS Pathology has been announced as the winner of the ‘Diagnostics...
Joint Venture partner Serco will be attending the 2011 NHS...
GSTS-KingsPath will have a stand at the EHA (European Hematology...
New Tests
Infection Sciences now offer the Cepheid GeneXpert MTB/RIF rapid molecular test that simultaneously identifies Mycobacterium Tuberculosis (MTB) and resistance to rifampicin (RIF). A 24 hour turnaround time is available for this test which can be performed on smear positive respiratory samples.
...The Infection and Immunology labs have recently introduced the C.Difficile Molecular Gene Expert Assay which increases assay sensitivity and clinical relevance. This enables effective infection control and compliance with national targets.
The DNA laboratory is developing assays using Next Generation Sequencing (NGS) to screen for heterogeneous genetic disorders. These assays can be used to test a large number of genes...
The Infection and Immunology department at GSTS is introducing a new screening protocol for Clostridium difficile from 1 September. The new protocol offers improved sensitivity and specificity through ...
The Nutristasis Unit now provides the new Active B12 (holotranscobalamin) marker and GSTS is the first provider in the UK to offer it outside the research environment.
The majority (up to 80%) of serum vitamin B12 is not bio-available. Current assays measure total vitamin B12 which leads to a grey...
GSTS offering Active B12 test
GSTS Pathology is the only pathology provider in the UK to perform the new Active B12 (holotranscobalamin) test for vitamin B12 deficiency. The new early marker complements GSTS' serum methylmalonic acid assay which is a functional marker of B12 and is more effective in picking up vitamin B12 deficiency than other current assays.
For more information on the Active B12 assay visit the New Test page or contact John Roberts.
GSTS offering ovarian cancer test
With recent calls from the National Institute for Health and Clinical Excellence (NICE) that women should be offered a blood test for ovarian cancer, GSTS reiterates that its Blood Sciences Department performs the CA-125 test for ovarian cancer.
To learn more about the CA-125 test at GSTS, contact Head of Blood Sciences, George Worthington.
More details on the NICE announcement can be found on the NICE website and the BBC website.
A-Z Test index
GSTS Pathology provides a constantly growing portfolio of tests to our customers and we perform more than seven million tests each year. To find a specific test, enter a keyword below, or to view all the tests GSTS provides visit the A-Z Test Index.
